. Author manuscript; available in PMC: 2012 Apr 1.

Published in final edited form as: Horm Behav. 2011 Feb 18;59(4):528–535. doi: 10.1016/j.yhbeh.2011.02.002

Table 1.

Mean ± SEM serum concentrations of morning cortisol (µg/dl) during each of the four treatment conditions in dominant females and subordinate females with an l/l or s-variant 5HTT genotype. Estradiol administration significantly attenuated serum cortisol (p < 0.001), indicated by different numbered superscripts. However, CRHA (corticotropin releasing-hormone receptor analogue) administration significantly increased serum cortisol (p = 0.001), indicated by a different lettered superscript. Serum cortisol did not differ significantly by status, genotype, or their interactions with treatments. See text for details.

Group	Placebo^{1, A}	CRHA^{1, B}	Estradiol^{2, A}	CRHA + Estradiol^{2, B}
Dom, l/l	27.9 ± 1.8	31.9 ± 2.4	23.0 ± 2.0	30.2 ± 2.3
Dom, s-variant	29.5 ± 2.6	34.6 ± 2.9	27.4 ± 1.9	30.6 ± 2.9
Subordinate, l/l	27.4 ± 1.7	32.1 ± 2.3	24.7 ± 1.8	28.4 ± 2.8
Subordinate, s-variant	28.6 ± 1.4	33.0 ± 1.9	26.3 ± 1.6	32.5 ± 2.4